Dr. Agarwal's Health Care Limited Allots 2,99,122 Equity Shares Under ESOP Scheme

2 min read     Updated on 12 Dec 2025, 10:01 PM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Dr. Agarwal's Health Care Limited allotted 2,99,122 equity shares under its ESOP scheme 2022 on December 12, 2025, with exercises at ₹84.93 and ₹129.88 per share. The allotment increased the company's paid-up capital from ₹31.62 crores to ₹31.65 crores, bringing total equity shares to 31,64,70,002. The transaction complies with SEBI regulations and the newly allotted shares rank pari passu with existing equity shares.

27102667

*this image is generated using AI for illustrative purposes only.

Dr. Agarwal's Health Care Limited has successfully completed the allotment of 2,99,122 equity shares to eligible employees under its Employee Stock Option Scheme 2022. The allotment, approved by the Nomination and Remuneration Committee through a circular resolution dated December 12, 2025, represents the exercise of vested stock options by company employees.

ESOP Allotment Details

The share allotment comprised two distinct exercise price categories, reflecting options granted and vested in different tranches:

Exercise Details: Number of Shares Price per Share
First Tranche: 2,81,722 shares ₹84.93
Second Tranche: 17,400 shares ₹129.88
Total Allotment: 2,99,122 shares Mixed pricing

The shares carry a face value of ₹1.00 each and have been allotted under the Dr. Agarwal's Health Care Limited - Employee Stock Option Scheme 2022. All allotted equity shares rank pari passu with the existing equity shares of the company, ensuring equal rights and privileges for the holders.

Impact on Share Capital

The ESOP exercise has resulted in a notable increase in the company's paid-up equity share capital:

Capital Structure: Before Allotment After Allotment
Paid-up Capital: ₹31,61,70,880 ₹31,64,70,002
Number of Shares: 31,61,70,880 31,64,70,002
Face Value per Share: ₹1.00 ₹1.00

The distinctive number range for the newly allotted shares spans from 31,61,70,881 to 31,64,70,002, with the ISIN code INE943P01029 applicable for demat issuance.

Regulatory Compliance

The allotment has been conducted in full compliance with Regulation 10(c) of the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company filed the required statement under regulation 10(b) with the recognized stock exchanges on February 24, 2025, receiving filing numbers BSE-224564 and NSE-NSE/LIST/47322.

Key regulatory aspects of the allotment include:

  • No lock-in period applicable on the allotted shares
  • Shares issued in demat form with ISIN INE943P01029
  • No additional listing fees payable for the allotment
  • Full compliance with SEBI regulations for employee stock option schemes

Company Information

Dr. Agarwal's Health Care Limited operates in the healthcare sector and maintains its registered office at 1st Floor, Buhari Towers, No. 4, Moore's Road, Off Greams Road, Near Asan Memorial School, Chennai-600006. The company's shares are listed on both BSE Limited (Scrip Code: 544350) and National Stock Exchange of India Limited (Symbol: AGARWALEYE), providing liquidity and accessibility to investors across major Indian stock exchanges.

Dr. Agarwal's Health Care Seeks Shareholder Approval for New Statutory Auditor

1 min read     Updated on 17 Nov 2025, 03:02 PM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Dr. Agarwal's Health Care Limited initiates postal ballot for appointing M/s. S.R. Batliboi & Associates LLP as new statutory auditors, replacing Deloitte Haskins & Sells. This change aligns with pre-merger activities involving subsidiary Dr. Agarwal's Eye Hospital Limited. E-voting period set from November 18 to December 17, with proposed auditor fee of ₹52.50 lakh for the upcoming financial year. The move aims to streamline audit processes across the group post-merger.

24917569

*this image is generated using AI for illustrative purposes only.

Dr. Agarwal's Health Care Limited has initiated a postal ballot process to seek shareholder approval for the appointment of a new statutory auditor. This move comes as part of the company's pre-merger alignment activities with its subsidiary, Dr. Agarwal's Eye Hospital Limited (AEHL).

Key Points of the Postal Ballot

  • New Auditor Proposed: M/s. S.R. Batliboi & Associates LLP, Chartered Accountants, is proposed to replace M/s. Deloitte Haskins & Sells.
  • Reason for Change: The change is part of pre-merger activities to align the statutory audit function across the group.
  • E-voting Period: From November 18 to December 17.
  • Proposed Auditor Fee: ₹52.50 lakh for the upcoming financial year.

Background and Rationale

The Board of Directors of Dr. Agarwal's Health Care and its material subsidiary AEHL approved a merger on August 27. Following this, AEHL appointed M/s. S.R. Batliboi & Associates LLP as their Statutory Auditors on September 24.

Dr. Agarwal's Health Care is now seeking to appoint the same audit firm to promote synergy, uniformity, and operational efficiency in audit processes across the group. This alignment is expected to streamline audit and reporting practices for the combined entity post-merger.

Resignation of Current Auditor

M/s. Deloitte Haskins & Sells have resigned effective November 12 to facilitate this change. The company stated that the outgoing auditors have not raised any concerns, and the resignation is solely to enable the appointment of AEHL's existing statutory auditors.

Proposed Auditor Details

M/s. S.R. Batliboi & Associates LLP, if approved, will serve as the Statutory Auditors until the conclusion of the 16th Annual General Meeting of the company. The firm, established in 1949, is part of S.R. Batliboi & Affiliates network and has offices across key Indian cities.

Voting Process

Shareholders can cast their votes electronically through the e-voting system provided by KFin Technologies Limited. The e-voting period is set from 9:00 AM IST on November 18 to 5:00 PM IST on December 17.

This move by Dr. Agarwal's Health Care Limited represents a significant step in their merger process and aims to enhance the efficiency of their audit procedures across the group structure.

More News on Dr. Agarwal's Health Care
Explore Other Articles